Vogliviga GM1/0.2 Tablet in PCD pharma franchise in Hyderabad

Vogliviga GM1/0.2 Tablet in pharmaceutical manufacturing company in Mumbai

Vogliviga GM1/0.2 Tablet in diabetic pharma franchise in Pune

Vogliviga GM1/0.2 Tablet in pharma suppliers in Delhi

Vogliviga GM1/0.2 Tablet in pharma export companies in Kolkata
Vogliviga GM1/0.2 Tablet in pharma franchise opportunities in Bengaluru

Keptos TH 4 Tablet

Composition : Thiocolchicoside 4 mg + Ketoprofen 50 mg

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹195/-

Please Contact For Best Price

Vogliviga GM1/0.2 Tablet is a triple combination medication designed to effectively manage type 2 diabetes mellitus. It contains Glimepiride 1mg, which stimulates insulin secretion; Voglibose 0.2mg, which delays carbohydrate absorption to reduce post-meal blood sugar spikes; and Metformin HCl 500mg, which enhances insulin sensitivity and decreases glucose production by the liver. The bi-layered tablet formulation ensures controlled release of Metformin, optimizing blood sugar control throughout the day. This combination provides comprehensive glycemic management by targeting multiple mechanisms.

Read More

About the Product

Vogliviga GM1/0.2 Tablet is a triple combination medication designed to effectively manage type 2 diabetes mellitus. It contains Glimepiride 1mg, which stimulates insulin secretion; Voglibose 0.2mg, which delays carbohydrate absorption to reduce post-meal blood sugar spikes; and Metformin HCl 500mg, which enhances insulin sensitivity and decreases glucose production by the liver. The bi-layered tablet formulation ensures controlled release of Metformin, optimizing blood sugar control throughout the day. This combination provides comprehensive glycemic management by targeting multiple mechanisms.

Possible side effects include gastrointestinal discomfort such as nausea, bloating, flatulence, and diarrhea. Hypoglycemia is a risk, particularly if meals are missed or doses are not properly managed. Long-term Metformin use may cause vitamin B12 deficiency in some patients.

Indicated for patients with type 2 diabetes requiring combination therapy to control both fasting and postprandial blood glucose levels.

Not recommended for patients with type 1 diabetes, severe liver or kidney impairment, or gastrointestinal disorders. Regular monitoring of blood glucose is essential. Avoid alcohol while on this medication. Follow your healthcare provider’s instructions carefully.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch